ÂÜÀòÂÒÂ×

Padmanee Sharma, PhD, MD, is a leading cancer immunotherapy scientist. Dr. Sharma currently serves as co-director of the Parker Institute for Cancer Immumotherapy and as Professor in the departments of Genitourinary Medical Oncology and Immunology at The University of Texas MD Anderson Cancer Center. A co-founder of Jounce Therapeutics, she is a medical oncologist and immunologist, and is the principal investigator of several immunotherapy clinical trials, which allows her to investigate immune responses and pathways critical for eliciting anti-tumor responses which provide clinical benefit in cancer patients.